Vanguard Portfolio Management »

4d Molecular Therapeutics In shares owned by Vanguard Portfolio Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Vanguard Portfolio Management from 13F filings

Historical chart of Vanguard Portfolio Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Vanguard Portfolio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Vanguard Portfolio Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.2M 556k 9.31